Трансляционная биомедицина

  • ISSN: 2172-0479
  • Индекс Хирша журнала: 16
  • Оценка цитируемости журнала: 5.91
  • Импакт-фактор журнала: 3.66
Индексировано в
  • Open J Gate
  • Журнал GenamicsSeek
  • ЖурналTOCs
  • ИсследованияБиблия
  • Глобальный импакт-фактор (GIF)
  • Китайская национальная инфраструктура знаний (CNKI)
  • CiteFactor
  • Шимаго
  • Библиотека электронных журналов
  • Справочник индексации исследовательских журналов (DRJI)
  • OCLC- WorldCat
  • Вызов запроса
  • Паблоны
  • МИАР
  • Комиссия по университетским грантам
  • Женевский фонд медицинского образования и исследований
  • Google Scholar
  • ШЕРПА РОМЕО
  • Секретные лаборатории поисковых систем
  • ResearchGate
Поделиться этой страницей

Абстрактный

Nonalcoholic fatty liver disease-An update on biomarkers and disease severity

Dr. Nabaneeta Mahata

Nonalcoholic fatty liver disease is a chronic liver disease with prevalence 9-40 percent in different areas of the world. It is estimated that it will become the most common cause for liver transplantation in the coming years. The major causes implicated for fatty liver who consume no or minimal alcohol are toxins environmental like carbon tetrachloride, ethionine, hepatitis B and C, chemicals like insecticides, pesticides, excess fat diet or defective nutrition like protein deficiency, essential nutrient deficiency like vitamin B 12, choline, methionine. In this research biochemical parameters like fasting glucose, insulin, Kidney function tests, liver function tests, lipid profile, serum electrolytes, total proteins and albumin, LDH and others were measured. Two novel biomarkers Adiponectin and Leptin were also measured with Enzyme linked immunosorbent assay. The extent and severity of these biochemical markers were statistically correlated with fibroscan, an established imaging study of liver which quantifies the extent of fatty infiltration called steatosis expressed in kilopascals and controlled attenuated parameters CAP expressed in decibels per meter. The study showed that there may be a correlation of these parameters with disease severity especially of Adiponectin. It may also be used as a therapeutic target in NAFLD.

Отказ от ответственности: Этот реферат был переведен с помощью инструментов искусственного интеллекта и еще не прошел проверку или верификацию